One of the underlying mechanisms for metabolic individuality is genetic variation. Single nucleotide polymorphisms (SNPs) in genes of metabolic pathways can create metabolic inefficiencies that alter the dietary requirement for, and responses to, nutrients. These SNPs can be detected using genetic profiling and the metabolic inefficiencies they cause can be detected using metabolomic profiling. Studies on the human dietary requirement for choline illustrate how useful these new approaches can be, as this requirement is influenced by SNPs in genes of choline and folate metabolism. In adults, these SNPs determine whether people develop fatty liver, liver damage and muscle damage when eating diets low in choline. Because choline is very important for fetal development, these SNPs may identify women who need to eat more choline during pregnancy. Some of the actions of choline are mediated by epigenetic mechanisms that permit ‘retuning’ of metabolic pathways during early life.

Keywords:
Choline, Development, Single nucleotide polymorphism, Epigenetics, Methylation
1.
Barker DJ: Maternal nutrition, fetal nutrition, and disease in later life. Nutrition 1997;13:807–813.
2.
Crawford DC, Nickerson DA: Definition and clinical importance of haplotypes. Annu Rev Med 2005;56:303–320.
3.
Carlquist JF, Anderson JL: Using pharmacogenetics in real time to guide warfarin initiation: a clinician update. Circulation 2011;124:2554–2559.
4.
Cornelis MC, El-Sohemy A: Coffee, caffeine, and coronary heart disease. Curr Opin Lipidol 2007;18:13–19.
5.
Bailey LB, Gregory JF 3rd: Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr 1999;129:919–922.
6.
da Costa KA, Kozyreva OG, Song J, Galanko JA, Fischer LM, Zeisel SH: Common genetic polymorphisms affect the human requirement for the nutrient choline. FASEB J 2006;20:1336–1344.
7.
Kohlmeier M, da Costa KA, Fischer LM, Zeisel SH: Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans. Proc Natl Acad Sci USA 2005;102:16025–16030.
8.
Cahill LE, Fontaine-Bisson B, El-Sohemy A: Functional genetic variants of glutathione S-transferase protect against serum ascorbic acid deficiency. Am J Clin Nutr 2009;90:1411–1417.
9.
Mattei J, Demissie S, Tucker KL, Ordovas JM: Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults. J Nutr 2009;139:2301–2308.
10.
Jirtle RL, Skinner MK: Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007;8:253–262.
11.
Zeisel SH: Epigenetic mechanisms for nutrition determinants of later health outcomes. Am J Clin Nutr 2009;89:1488S–1493S.
12.
Shi Y, Zhao X, Hsieh J, Wichterle H, Impey S, Banerjee S, Neveu P, Kosik KS: MicroRNA regulation of neural stem cells and neurogenesis. J Neurosci 2010;30:14931–14936.
13.
Waterland RA, Lin JR, Smith CA, Jirtle RL: Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. Hum Mol Genet 2006;15:705–716.
14.
Waterland RA, Jirtle RL: Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003;23:5293–5300.
15.
Wolff GL, Kodell RL, Moore SR, Cooney CA: Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 1998;12:949–957.
16.
Waterland RA, Travisano M, Tahiliani KG, Rached MT, Mirza S: Methyl donor supplementation prevents transgenerational amplification of obesity. Int J Obes (Lond) 2008;32:1373–1379.
17.
Waterland RA, Dolinoy DC, Lin JR, Smith CA, Shi X, Tahiliani KG: Maternal methyl supplements increase offspring DNA methylation at Axin fused. Genesis 2006;44:401–406.
18.
Craciunescu CN, Albright CD, Mar MH, Song J, Zeisel SH: Choline availability during embryonic development alters progenitor cell mitosis in developing mouse hippocampus. J Nutr 2003;133:3614–3618.
19.
Mehedint MG, Craciunescu CN, Zeisel SH: Maternal dietary choline deficiency alters angiogenesis in fetal mouse hippocampus. Proc Natl Acad Sci USA 2010;107:12834–12839.
20.
Zeisel SH: Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr 2006;26:229–250.
21.
Vance DE, Walkey CJ, Cui Z: Phosphatidylethanolamine N-methyltransferase from liver. Biochim Biophys Acta 1997;1348:142–150.
22.
Fischer LM, daCosta K, Kwock L, Stewart P, Lu TS, Stabler S, Allen R, Zeisel S: Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr 2007;85:1275–1285.
23.
da Costa KA, Gaffney CE, Fischer LM, Zeisel SH: Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load. Am J Clin Nutr 2005;81:440–444.
24.
Zeisel SH, da Costa KA, Franklin PD, Alexander EA, Lamont JT, Sheard NF, Beiser A: Choline, an essential nutrient for humans. FASEB J 1991;5:2093–2098.
25.
Resseguie M, Song J, Niculescu MD, da Costa KA, Randall TA, Zeisel SH: Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes. FASEB J 2007;21:2622–2632.
26.
Resseguie ME, da Costa KA, Galanko JA, Patel M, Davis IJ, Zeisel SH: Aberrant estrogen regulation of PEMT results in choline deficiency-associated liver dysfunction. J Biol Chem 2011;286:1649–1658.
27.
Sha W, da Costa KA, Fischer LM, Milburn MV, Lawton KA, Berger A, Jia W, Zeisel SH: Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline. FASEB J 2010;24:2962–2975.
28.
Sweiry JH, Yudilevich DL: Characterization of choline transport at maternal and fetal interfaces of the perfused guinea-pig placenta. J Physiol 1985;366:251–266.
29.
Fischer LM, da Costa KA, Galanko J, Sha W, Stephenson B, Vick J, Zeisel SH: Choline intake and genetic polymorphisms influence choline metabolite concentrations in human breast milk and plasma. Am J Clin Nutr 2010;92:336–346.
30.
Zeisel SH, Epstein MF, Wurtman RJ: Elevated choline concentration in neonatal plasma. Life Sci 1980;26:1827–1831.
31.
Ilcol YO, Ozbek R, Hamurtekin E, Ulus IH: Choline status in newborns, infants, children, breast-feeding women, breast-fed infants and human breast milk. J Nutr Biochem 2005;16:489–499.
32.
Zeisel SH, Mar MH, Zhou Z, da Costa KA: Pregnancy and lactation are associated with diminished concentrations of choline and its metabolites in rat liver. J Nutr 1995;125:3049–3054.
33.
Meck WH, Williams CL, Cermak JM, Blusztajn JK: Developmental periods of choline sensitivity provide an ontogenetic mechanism for regulating memory capacity and age-related dementia. Front Integr Neurosci 2007;1:7.
34.
Meck WH, Williams CL: Metabolic imprinting of choline by its availability during gestation: implications for memory and attentional processing across the lifespan. Neurosci Biobehav Rev 2003;27:385–399.
35.
Meck WH, Smith RA, Williams CL: Pre- and postnatal choline supplementation produces long-term facilitation of spatial memory. Dev Psychobiol 1988;21:339–353.
36.
Meck WH, Williams CL: Choline supplementation during prenatal development reduces proactive interference in spatial memory. Brain Res 1999;118:51–59.
37.
Albright CD, Tsai AY, Friedrich CB, Mar MH, Zeisel SH: Choline availability alters embryonic development of the hippocampus and septum in the rat. Brain Res 1999;113:13–20.
38.
Albright CD, Friedrich CB, Brown EC, Mar MH, Zeisel SH: Maternal dietary choline availability alters mitosis, apoptosis and the localization of TOAD-64 protein in the developing fetal rat septum. Brain Res 1999;115:123–129.
39.
Albright CD, Mar MH, Craciunescu CN, Song J, Zeisel SH: Maternal dietary choline availability alters the balance of netrin-1 and DCC neuronal migration proteins in fetal mouse brain hippocampus. Brain Res Dev Brain Res 2005;159:149–154.
40.
Niculescu MD, Craciunescu CN, Zeisel SH: Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains. FASEB J 2006;20:43–49.
41.
Niculescu MD, Yamamuro Y, Zeisel SH: Choline availability modulates human neuroblastoma cell proliferation and alters the methylation of the promoter region of the cyclin-dependent kinase inhibitor 3 gene. J Neurochem 2004;89:1252–1259.
42.
Thomas JD, Garrison M, O’Neill TM: Perinatal choline supplementation attenuates behavioral alterations associated with neonatal alcohol exposure in rats. Neurotoxicol Teratol 2004;26:35–45.
43.
Fisher MC, Zeisel SH, Mar MH, Sadler TW: Perturbations in choline metabolism cause neural tube defects in mouse embryos in vitro. FASEB J 2002;16:619–621.
44.
Fisher MC, Zeisel SH, Mar MH, Sadler TW: Inhibitors of choline uptake and metabolism cause developmental abnormalities in neurulating mouse embryos. Teratology 2001;64:114–122.
45.
Shaw GM, Carmichael SL, Yang W, Selvin S, Schaffer DM: Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol 2004;160:102–109.
46.
Shaw GM, Carmichael SL, Laurent C, Rasmussen SA: Maternal nutrient intakes and risk of orofacial clefts. Epidemiology 2006;17:285–291.
47.
Signore C, Ueland PM, Troendle J, Mills JL: Choline concentrations in human maternal and cord blood and intelligence at 5 y of age. Am J Clin Nutr 2008;87:896–902.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.